[ad_1]
Tilray, who is engaged in research, cultivation, processing and distribution of medicinal marijuana worldwide, was the first of its kind to make an initial public offering on a US stock exchange.
was carried out under the label "TLRY", with an offer of nine million shares and a reference price of 17 dollars (14.6 euros). After the 31.71% increase recorded on the day of its debut, the value of the bond Tilray closed the session at $ 22.39
The company has cashed $ 153 million from its IPO and its market value According to analysts, $ 1.43 billion, which tracked most new investors in the United States.
This specialized company joins two other Canadian marijuana companies already on the US market, Cronos, which debuted on the Nasdaq in February, and Canopy, which began in May.
These two companies were already listed on Canadian stock exchanges, unlike Tilray, which chose the United States to make its initial public offering, coinciding with the timing of Canada's launch. to legalize the factory in the near future.
Tilray is controlled by the US investment firm Privateer, which intends to retain part of the income now earned and to allocate another part to the financing of new cultivation facilities and transformation in Ontario.
[ad_2]
Source link
